Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 May 4;11(1):9467.
doi: 10.1038/s41598-021-89077-8.

Management of ongoing direct anticoagulant treatment in patients with hip fracture

Carlo Rostagno  1   2   3 , Alessandro Cartei  4 , Gianluca Polidori  4 , Roberto Civinini  5 , Alice Ceccofiglio  4 , Gaia Rubbieri  4 , Massimo Curcio  4 , Alberto Boccaccini  6 , Adriano Peris  5 , Domenico Prisco  7
Affiliations
Observational Study

Management of ongoing direct anticoagulant treatment in patients with hip fracture

Carlo Rostagno et al. Sci Rep. .

Abstract

Aim of the present study was to investigate the effects of ongoing treatment with DOACs on time from trauma to surgery and on in-hospital clinical outcomes (blood losses, need for transfusion, mortality) in patients with hip fracture. Moreover we evaluated the adherence to current guidelines regarding the time from last drug intake and surgery. In this observational retrospective study clinical records of patients admitted for hip fracture from January 2016 to January 2019 were reviewed. 74 patients were in treatment with DOACs at hospital admission. Demographic data, comorbidities and functional status before trauma were retrieved. As control group we evaluated 206 patients not on anticoagulants matched for age, gender, type of fracture and ASA score. Time to surgery was significantly longer in patients treated with DOACs (3.6 + 2.7 vs. 2.15 ± 1.07 days, p < 0.0001) and treatment within 48 h was 47% vs. 80% in control group (p < 0.0001). The adherence to guidelines' suggested time from last drug intake to surgery was 46%. Neither anticipation nor delay in surgery did result in increased mortality, length of stay or complication rates with the exception of larger perioperative blood loss (Hb levels < 8 g/dl) in DOACs patients (34% vs 9% p < 0.0001). Present results suggest that time to surgery is significantly longer in DOAC patients in comparison to controls and adherence to guidelines still limited.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Kim SH, Meehan JP, Blumenfeld T, Szabo RM. Hip fractures in the United States: 2008 nationwide emergency department sample. Arthritis Care Res. 2012;64:751–757. doi: 10.1002/acr.21580. - DOI - PubMed
    1. Haentjens P, et al. Meta-analysis: Excess mortality after hip fracture among older women and men. Ann. Intern. Med. 2010;152(6):380–390. doi: 10.7326/0003-4819-152-6-201003160-00008. - DOI - PMC - PubMed
    1. Veronese N, Maggi S. Epidemiology and social costs of hip fracture. Injury. 2018;49:1458–1460. doi: 10.1016/j.injury.2018.04.015. - DOI - PubMed
    1. Moja L, et al. Timing matters in hip fracture surgery: Patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients. PLoS ONE. 2012;7:e46175. doi: 10.1371/journal.pone.0046175. - DOI - PMC - PubMed
    1. Eardley WG, Macleod KE, Freeman H, Tate A. “Tiers of Delay”: Warfarin, hip fractures, and target-driven care. Geriatr. Orthop. Surg. Rehabil. 2014;5(3):103–108. doi: 10.1177/2151458514532469. - DOI - PMC - PubMed

Publication types